Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 0.95B P/E - EPS this Y 21.20% Ern Qtrly Grth -
Income -40.85M Forward P/E -21.37 EPS next Y 15.70% 50D Avg Chg -7.00%
Sales 150.71M PEG -1.74 EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 9.18 EPS next 5Y 8.90% 52W High Chg -17.00%
Recommedations 1.80 Quick Ratio 8.01 Shares Outstanding 41.69M 52W Low Chg 121.00%
Insider Own 2.41% ROA -12.51% Shares Float 37.38M Beta 1.23
Inst Own 99.55% ROE -23.88% Shares Shorted/Prior 1.65M/1.56M Price 24.57
Gross Margin 77.69% Profit Margin -27.10% Avg. Volume 448,664 Target Price 23.56
Oper. Margin -25.22% Earnings Date Nov 4 Volume 271,300 Change -4.32%
About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-BONE, Inc. News
11/20/24 SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
11/15/24 SI-BONE, Inc. (NASDAQ:SIBN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
11/14/24 SI-BONE Third Quarter 2024 Earnings: EPS Beats Expectations
11/13/24 Q3 2024 SI-BONE Inc Earnings Call
11/13/24 SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to Profitability
11/12/24 Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue Estimates
11/12/24 Si-Bone: Q3 Earnings Snapshot
11/12/24 SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
11/07/24 Artivion (AORT) Tops Q3 Earnings and Revenue Estimates
11/05/24 SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™
10/30/24 Strength Seen in Si-Bone (SIBN): Can Its 6.9% Jump Turn into More Strength?
10/22/24 SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024
10/14/24 SIBN Stock Up After First-In-Patient Use of FDA Breakthrough Device
10/14/24 First patients are treated with Si-Bone’s pelvic fracture fixation device
10/10/24 SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
08/26/24 Wall Street Analysts Think Si-Bone (SIBN) Could Surge 40.3%: Read This Before Placing a Bet
08/26/24 SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System
08/22/24 SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
08/20/24 SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
08/08/24 Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.45%: Here's is How to Trade
SIBN Chatroom

User Image GeniusLoci Posted - 4 days ago

$SIBN Stochastic Buy Signal

User Image RocketThief Posted - 1 week ago

$SIBN in

User Image Chiroptera_Capital Posted - 1 week ago

$SIBN results look great. Very small rev miss means nothing against the business advancing on all fronts. Managed to scoop 100 shares in AH at $12

User Image d_risk Posted - 1 week ago

$SIBN - SI-Bone - 10Q - Updated Risk Factors New risk factor: Compliance with healthcare fraud and abuse laws is crucial, with DOJ investigation underscoring risks. Credit market conditions may restrict favorable funding access. #Risk https://d-risk.ai/SIBN/10-Q/2024-11-12

User Image insiderbuyingselling Posted - 2 weeks ago

$SIBN new insider selling: 341 shares. http://insiderbuyingselling.com/?t=SIBN

User Image swingingtech Posted - 10/30/24

$SIBN $NSPR https://wallstreetwaves.com/si-bone-sibn-sees-6-9-surge-will-this-momentum-lead-to-continued-growth/

User Image Will2ride1 Posted - 10/23/24

$SIBN on watch

User Image Chiroptera_Capital Posted - 10/23/24

$SIBN I’m a buyer today

User Image cleverrox Posted - 1 month ago

$SIBN losing $40M a year and trading at 3.5X sales. $ASAPF trading at less than 2X sales and about to be profitable EPS

User Image cleverrox Posted - 1 month ago

$SIBN - I would sell SIBN and buy $ASAPF instead. https://microcapopportunities.substack.com/p/aurora-spine-nothing-nothing-nothing

User Image BioTuesdays Posted - 1 month ago

SI-BONE reports first in-patient procedures with TNT implant system for pelvic fractures $SIBN https://biotuesdays.com/2024/10/10/si-bone-reports-first-in-patient-procedures-with-tnt-implant-system-for-pelvic-fractures/

User Image StockDoctorBio Posted - 1 month ago

$SIBN fast growing medical device company with nice entry discount today on low volume

User Image insiderbuyingselling Posted - 1 month ago

$SIBN new insider selling: 4226 shares. http://insiderbuyingselling.com/?t=SIBN

User Image kindness123 Posted - 08/26/24

$SIBN on watch 😅

User Image Himel92 Posted - 08/23/24

The Last month Performance for $SIBN Opening Price: $16.92 Closing Price: $14.90 Highest Price: $17.29 Lowest Price: $13.31 Percentage Change: -11.94% Data analyst: AITX

User Image GeniusLoci Posted - 08/23/24

$SIBN

User Image insiderbuyingselling Posted - 3 months ago

$SIBN new insider selling: 2418 shares. http://insiderbuyingselling.com/?t=SIBN

User Image Stock_Titan Posted - 3 months ago

$SIBN SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System https://www.stocktitan.net/news/SIBN/si-bone-inc-receives-510-k-clearance-and-fda-breakthrough-device-s302f4izf144.html

User Image StockInvest_us Posted - 3 months ago

Signal alert: $SIBN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/0lMBDCmaDY

User Image Stocksrunner Posted - 3 months ago

Midweek Upgrades Signal Promising Opportunities $UPBD $SIBN $PRM $PLOW https://stocksrunner.com/posts?id=1010

User Image epsguid Posted - 3 months ago

$SIBN reported a loss of $0.22, consensus was ($0.26) via @eWhispers #epsbeat http://eps.sh/d/sibn

User Image Stock_Titan Posted - 3 months ago

$SIBN SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 https://www.stocktitan.net/news/SIBN/si-bone-inc-reports-financial-results-for-the-second-quarter-mdxk93h3x1ht.html

User Image NVDAMillionaire Posted - 3 months ago

$SIBN SI-BONE, Inc. (NASDAQ:SIBN) – Pioneering Sacropelvic Solutions with Robust Growth Potential http://beyondspx.com/2024/08/02/si-bone-inc-nasdaqsibn-pioneering-sacropelvic-solutions-with-robust-growth-potential/

User Image Stock_Titan Posted - 4 months ago

$SIBN SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024 https://www.stocktitan.net/news/SIBN/si-bone-to-report-second-quarter-2024-financial-results-on-august-5-f66f5edqo2r2.html

User Image insiderbuyingselling Posted - 4 months ago

$SIBN new insider selling: 3309 shares. http://insiderbuyingselling.com/?t=SIBN

User Image GeniusLoci Posted - 06/25/24

$SIBN Stochastic Buy Signal

User Image RocketThief Posted - 5 months ago

$SIBN time to start buying here at EV of ~2.6x ‘24 guidance

User Image Ortho91 Posted - 6 months ago

$SIBN they’re gonna be acquired by Globus, Nuvasive, or Medtronic sooner than later. Best in class sacro-iliac fusion product on the market. It’s just a matter of when and the longer the wait the higher the BO will be.

User Image Stock_Titan Posted - 6 months ago

$SIBN SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures https://www.stocktitan.net/news/SIBN/si-bone-expands-portfolio-with-the-launch-of-new-offering-for-the-i-efzx2f3c1w9q.html

User Image DonCorleone77 Posted - 6 months ago

$SIBN SI-Bone reports Q1 EPS (27c), consensus (31c) Reports Q1 revenue $37.9M, consensus $36.49M. "I am pleased with the solid start to the year as we continued to benefit from robust procedure volumes across all our target markets and maintained our strong procedure ASP," said Laura Francis, Chief Executive Officer. "I am confident about our revenue growth acceleration, catalyzed by expansion of our opportunity in the pelvic fixation market with the rollout of the smaller diameter Granite implant and building on the success of iFuse 3D with the adoption of TORQ across all our call points. This top-line growth will also allow us to make significant progress towards our adjusted EBITDA breakeven goal."

Analyst Ratings
Morgan Stanley Overweight Aug 6, 24
Truist Securities Buy Aug 6, 24
Needham Buy Aug 6, 24
Morgan Stanley Overweight Jul 15, 24
Morgan Stanley Overweight May 7, 24
JMP Securities Market Outperform May 7, 24
Needham Buy May 7, 24
Needham Buy Apr 3, 24
Piper Sandler Overweight Mar 28, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DUNN JEFFREY W Director Director Feb 02 Sell 20.2968 335 6,799 44,383 02/05/24
Davis Timothy E JR Director Director Jan 02 Option 3.24 21,111 68,400 43,472 01/09/24
Davis Timothy E JR Director Director Jan 02 Sell 20.9314 9,900 207,221 22,361 01/04/24
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jan 02 Sell 20.9253 1,936 40,511 198,903 01/04/24
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Jan 02 Sell 20.924 1,470 30,758 147,268 01/04/24
DUNN JEFFREY W Director Director Nov 16 Sell 17.69 7,965 140,901 44,718 11/20/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Nov 16 Sell 17.66 8,457 149,351 200,839 11/20/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Nov 16 Sell 17.58 1,733 30,466 148,738 11/20/23
DUNN JEFFREY W Director Director Oct 21 Sell 17.52 406 7,113 52,683 11/06/23
DUNN JEFFREY W Director Director Oct 02 Sell 21.19 20,000 423,800 69,645 10/04/23
DUNN JEFFREY W Director Director Oct 02 Option 4.32 20,000 86,400 89,645 10/04/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Oct 02 Sell 21.1576 1,712 36,222 209,296 10/04/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Oct 02 Sell 21.1494 1,244 26,310 150,471 10/04/23
DUNN JEFFREY W Director Director Sep 01 Sell 22.61 20,000 452,200 69,645 09/06/23
DUNN JEFFREY W Director Director Sep 01 Option 4.32 20,000 86,400 89,645 09/06/23
DUNN JEFFREY W Director Director Aug 11 Sell 21.48 20,000 429,600 77,609 08/15/23
DUNN JEFFREY W Director Director Aug 11 Option 4.32 20,000 86,400 97,609 08/15/23
DUNN JEFFREY W Director Director Aug 02 Sell 25.0763 406 10,181 77,609 08/03/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Jul 03 Sell 26.7032 1,244 33,219 153,448 07/05/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jul 03 Sell 26.6848 1,712 45,684 219,490 07/05/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jun 15 Sell 28.59 48 1,372 221,202 06/20/23
HILLEMAN JERYL L Director Director Jun 15 Sell 28.37 4,162 118,076 15,349 06/20/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Jun 07 Sell 28.00 3,272 91,616 154,692 06/09/23
DUNN JEFFREY W Director Director May 09 Sell 22 272,753 6,000,566 85,166 05/10/23
DUNN JEFFREY W Director Director May 09 Option 3.42 272,753 932,815 357,919 05/10/23
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Apr 03 Sell 19.2995 1,229 23,719 159,697 04/05/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Apr 03 Sell 19.2816 1,712 33,010 227,815 04/05/23
DUNN JEFFREY W Director Director Feb 03 Sell 18.22 302 5,502 111,371 02/07/23
DUNN JEFFREY W Director Director Jan 17 Sell 16.1435 1,739 28,074 101,992 01/18/23
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Jan 17 Sell 16.1821 399 6,457 172,108 01/18/23
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jan 17 Sell 16.1 1,948 31,363 237,901 01/18/23
DUNN JEFFREY W Director Director Oct 17 Sell 18.3406 2,114 38,772 113,842 10/18/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Oct 17 Sell 18.5218 587 10,872 168,676 10/18/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Oct 17 Sell 18.3869 355 6,527 119,539 10/18/22
DUNN JEFFREY W Director Director Aug 16 Sell 17.29 7,965 137,715 124,027 08/17/22
FRANCIS LAURA Chief Executive Offi.. Chief Executive Officer Aug 16 Sell 17.29 5,248 90,738 326,147 08/17/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Aug 16 Sell 17.29 5,463 94,455 169,263 08/17/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Aug 16 Sell 17.29 3,475 60,083 119,894 08/17/22
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer Aug 16 Sell 17.29 1,709 29,549 89,487 08/17/22
DUNN JEFFREY W Director Director Jul 15 Sell 14.2794 2,116 30,215 135,267 07/18/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Jul 15 Sell 14.2794 355 5,069 123,369 07/18/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Jun 15 Sell 14.28 588 8,397 174,726 07/18/22
Maheshwari Anshul Chief Financial Offi.. Chief Financial Officer May 16 Sell 12.58 4,111 51,716 91,196 05/17/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops May 16 Sell 12.58 5,466 68,762 175,214 05/17/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr May 16 Sell 12.58 3,466 43,602 123,724 05/17/22
FRANCIS LAURA Chief Executive Offi.. Chief Executive Officer May 16 Sell 12.58 4,805 60,447 331,395 05/17/22
DUNN JEFFREY W Director Director May 16 Sell 12.58 5,608 70,549 137,383 05/17/22
Pisetsky Michael A SVP, Ops & Adm/Chief.. SVP, Ops & Adm/Chief Legal Ofr Apr 18 Sell 19.9238 349 6,953 126,056 04/20/22
DUNN JEFFREY W Director Director Apr 18 Sell 19.9238 1,474 29,368 152,285 04/20/22
RECUPERO ANTHONY J President, Commercia.. President, Commercial Ops Apr 18 Sell 19.9238 577 11,496 179,545 04/20/22